Skip to content

Lateral Lymph Node Dissection for Middle-low Rectal Cancer

Prospective Study on Image-guided Internal Iliac Vessels Dissection and Node-for-node for Selected Lateral Lymph Node Dissection in Middles-low Rectal Cancer

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03826862
Enrollment
30
Registered
2019-02-01
Start date
2018-10-01
Completion date
2022-12-30
Last updated
2019-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

lateral lymph node dissection, node-by-node, rectal cancer, CT three-dimensional reconstruction, internal iliac vessels dissection

Brief summary

The investigators will perform CT three-dimension reconstruction for middle-low rectal cancer patients who have enlarged lateral lymph nodes to recognize the variance of pelvic vessels, by which to help reduce operative time and blood loss, localize the lateral lymph nodes, improve the lymph node harvested and positive rate. Besides, The investigators will label the vessels near the interested node to achieve node-by-node for further investigation.

Detailed description

CT three-dimensional reconstruction was performed for middle-low patients who had enlarged lateral lymph node before surgery. The main purpose is to recognize the track and variance of pelvic and iliac blood vessels. The investigators want to explore whether this method can help reduce operative time, unexpected injuries and blood loss, and The investigators also want to study whether it can help improve the lymph node harvested and positive rate during lateral lymph node dissection. Besides, The investigators want to perform node-by-node for enlarged lateral lymph node and CT three-dimensional reconstruction can help the investigators to localize and label the interested lymph node during operation. After node-by-node, The investigators can explore the accuracy of radiologists' and surgeons' judgement for lateral lymph node metastasis, and The investigators also want explore the best cut-off value of shorter diameter to predict lateral lymph node metastasis. Besides, The investigators want to perform texture analysis by combination radiology and pathology to find some useful parameters to predict lateral lymph node metastasis. The investigators also want to explore the feasibility of dissecting the unilateral visceral branch of internal iliac vessels when performing lateral lymph node dissection. The investigators will have a close follow-up for patients who have enlarged lateral lymph node but do not meet the criteria for lateral lymph node dissection. CT three-dimensional reconstruction can help The investigators recognize which parts' lateral lymph nodes have more potential possibility to metastasis and recurrence.

Interventions

RADIATIONCT three-dimensional reconstruction

All patients will receive CT three dimensional reconstruction before surgery

Sponsors

Ziqiang Wang,MD
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This group with intervention will be compared previous group without intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1) confirmed rectal cancer; 2) tumor located less than 10 cm from the anus verge; 3) have enlarged lateral lymph on preoperative CT/MRI

Exclusion criteria

1) patients who have severe liver or renal dysfunction;

Design outcomes

Primary

MeasureTime frameDescription
postoperative complication2 yearincluding urinary and sexual function
lateral lymph node harvested2 yearlateral lymph node harvested
Cut-off value of shorter diameter2 yearThe best cut-off value of shorter diameter for lateral lymph node dissection
vessels variancesOctober 1. 2018-December 31.2020The blood vessels variance of internal iliac vessels
Blood loss2 yearintraoperative blood loss
Accuracy of judgement for lateral lymph node metastasis2 yearincluding radiologists' and surgeons' accuracy
operative time2 yearincluding total operative time and that for lateral lymph node

Secondary

MeasureTime frameDescription
local recurrence rate3 yearlocal recurrence rate
overall survival3 yearoverall survival
disease-free survival3 yeardisease-free survival

Countries

China

Contacts

Primary ContactZiqiang Wang, MD
xbzhang262402@163.com+8618980602028

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026